Related references
Note: Only part of the references are listed.Introduction of Ertapenem into a Hospital Formulary: Effect on Antimicrobial Usage and Improved In Vitro Susceptibility of Pseudomonas aeruginosa
Ellie J. C. Goldstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Impact of Ertapenem Use on the Susceptibility of Pseudomonas aeruginosa to Imipenem: A Hospital Case Study
Ana Lucia L. Lima et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents
Paul P. Cook et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Ertapenem: No effect on aerobic gram-negative susceptibilities to imipenem
Debra A. Goff et al.
JOURNAL OF INFECTION (2008)
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality
Mitchell J. Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections:: a matched case-control study
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Imipenem resistance among Pseudomonas aeruginosa isolates:: Risk factors for infection and impact of resistance on clinical and economic outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates
J Quale et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients
YG Kwak et al.
MICROBIAL DRUG RESISTANCE (2005)
Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems
DM Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram
PP Cook et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
DM Livermore
CLINICAL INFECTIOUS DISEASES (2002)
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia
DM Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
